Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Bluebird’s new gene therapy among three new EMA OKs ahead of FDA
Endpoints
Fri, 05/21/21 - 10:56 am
gene therapy
Bluebird Bio
EMA
GSK
Vir
COVID-19
Skysona
monoclonal antibodies
Bylvay
Roche's Spark sues gene therapy rival bluebird for using 'spark' in its marketing campaigns
Fierce Pharma
Thu, 05/20/21 - 11:15 am
Roche
Spark Therapeutics
Bluebird Bio
gene therapy
trademark
Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech
Fierce Biotech
Wed, 05/19/21 - 10:31 am
Novartis
gene therapy
Tevard Biosciences
Funding News: Three Biopharmas Score a Combined $261 Million to Advance Pipelines
BioSpace
Tue, 05/18/21 - 11:21 pm
funding
Hummingbird Biosciences
eureKARE
microbiome
Interius BioTherapeutics
cell therapy
gene therapy
Sarepta touts clean data for commercial grade Duchenne gene therapy, clearing key hurdle to PhIII
Endpoints
Tue, 05/18/21 - 11:11 am
Sarepta
Duchenne Muscular Dystrophy
clinical trials
gene therapy
Biogen gene therapy for rare eye disease falls short in key clinical trial
MedCity News
Sun, 05/16/21 - 11:26 pm
Biogen
gene therapy
clinical trials
X-linked retinitis pigmentosa
cotoretigene toliparvovec
Biogen looks to build better gene therapies through latest deal
BioPharma Dive
Tue, 05/11/21 - 11:45 am
Biogen
gene therapy
Capsigen
Using AI for Gene Therapy Design, Dyno Scoops Up $100 Million to Expand Platform
BioSpace
Thu, 05/6/21 - 11:12 pm
Dyno Therapeutics
gene therapy
funding
artificial intelligence
Gene therapies in the knee? With the help of a small herd of horses, a new startup hopes to crack osteoarthritis
Endpoints
Wed, 05/5/21 - 10:32 am
gene therapy
osteoarthritis of the knee
animal studies
Genascence
Gene therapy funding frenzy reaches Affinia as it reels in $110M in new capital
MedCity News
Mon, 05/3/21 - 11:04 pm
Affinia Therapeutics
funding
gene therapy
Sarepta's second-gen Duchenne drug shows signs of topping its first
BioPharma Dive
Mon, 05/3/21 - 10:54 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
SRP-9001
gene therapy
Epidermolysis bullosa gene therapies wait in the wings
EP Vantage
Thu, 04/29/21 - 10:50 am
epidermolysis bullosa
Amryt
Filsuvez
gene therapy
Adverum gene therapy trial sees disruption after serious side effect reported
Biopharma Reporter
Thu, 04/29/21 - 10:39 am
Adverum Biotechnologies
diabetic macular edema
gene therapy
clinical trials
Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
Fierce Biotech
Tue, 04/27/21 - 10:47 am
Astellas
Audentes
AT132
gene therapy
FDA says Voyager can trek on as it removes trial hold for Huntington's gene therapy test
Fierce Biotech
Mon, 04/26/21 - 11:15 am
FDA
Voyager Therapeutics
VY-HTT01
gene therapy
Huntington's disease
FDA lifts clinical hold on uniQure's gene therapy amid cancer concerns; shares jump
Fierce Biotech
Mon, 04/26/21 - 12:06 pm
uniQure
hemophilia
gene therapy
FDA
Bayer plots a major facelift at Berkeley campus, uncorking a 30-year, $1.2B plan to drive cell and gene therapies
Endpoints
Thu, 04/22/21 - 11:29 pm
Bayer
Berkeley
cell therapy
gene therapy
Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag
Fierce Pharma
Tue, 04/20/21 - 07:38 pm
Bluebird Bio
Zynteglo
reimbursement
layoffs
Germany
gene therapy
Avrobio is using 'pods' to create gene therapies, and it believes the approach could change the game altogether
Endpoints
Fri, 04/16/21 - 12:01 am
Avrobio
gene therapy
drug manufacturing
Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery
Endpoints
Wed, 04/14/21 - 09:37 am
Audentes
Astellas
gene therapy
clinical trials
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »